What is Matter?
Founded in 2015, Matter operates on the principle that collaboration is the most effective catalyst for improving healthcare outcomes. The organization fosters a unique ecosystem by bringing together a global network of startups with hospitals, health systems, universities, and industry leaders. This synergistic approach aims to expedite innovation, enhance patient care, and ultimately improve lives by addressing complex challenges within the healthcare landscape. Matter's model is designed to de-risk innovation and accelerate the adoption of new technologies and solutions.
How much funding has Matter raised?
Matter has raised a total of $39.4M across 2 funding rounds:
Unspecified
$4.4M
Series A
$35M
Unspecified (2014): $4.4M with participation from AbbVie Inc., Astellas Pharma, and Marathon Pharmaceuticals, LLC
Series A (2022): $35M led by Jordan Park Group
Key Investors in Matter
AbbVie Inc.
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life.
Astellas Pharma
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Marathon Pharmaceuticals, LLC
Marathon Pharmaceuticals, LLC, is a biopharmaceutical company that develops treatments for rare diseases, with a focus on patients who currently have no treatment options. The company's pipeline of new medicines includes treatments for rare neurological and movement disorders.
What's next for Matter?
The recent major strategic investment signals Matter's readiness for its next phase of expansion, likely focusing on scaling its collaborative platforms and broadening its impact across the healthcare industry. With a strong foundation built on partnerships and a clear mission to drive innovation, Matter is well-positioned to continue its growth. Future initiatives may involve expanding its network of corporate partners, investing in promising early-stage healthcare ventures, and further developing its infrastructure to support a growing cohort of innovators. The enterprise-level funding context suggests a strategic push towards market leadership and significant operational scaling.
See full Matter company page
